Gerresheimer AGGRRMF +0.75%66 EV-to-FCF is -59.98 as of Jul. 01, 2026. GuruFocus rates GRRMF with a GF Score™ of 66/100 and a GF Value™ of $109.15 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 419 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 238663.25% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gerresheimer AG's Enterprise Value is $3,384 Mil.
Gerresheimer AG's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2025 was $-56 Mil. Therefore, Gerresheimer AG's EV-to-FCF for today is -59.98.
The historical rank and industry rank for Gerresheimer AG's EV-to-FCF or its related term are showing as below:
GRRMF'
s EV-to-FCF Range Over the Past 10 Years
Min: -1044.89 Med: 30.52 Max: 1815.58
Current: -59.98
During the past 13 years, the highest EV-to-FCF of Gerresheimer AG was 1815.58. The lowest was -1044.89. And the median was 30.52.
GRRMF's EV-to-FCF is ranked worse than 100% of 419
companies
in the Medical Devices & Instruments industry
Industry Median: 22.57
vs GRRMF: -59.98
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gerresheimer AG (OTCPK:GRRMF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gerresheimer AG's PE Ratio (TTM) for today is calculated as:
Gerresheimer AG's share price for today is $30.73.
Gerresheimer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.725.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Gerresheimer AG EV-to-FCF Related Terms
Gerresheimer AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's EV-to-FCF falls into.
Gerresheimer AG's current Enterprise Value is $3,384 Mil.
Gerresheimer AG's Free Cash Flow for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-56 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a EV-to-FCF of -59.98 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #999999 out of 419 companies in the Medical Devices & Instruments industry.
Is Gerresheimer AG's EV-to-FCF too high?
Gerresheimer AG's current EV-to-FCF is -59.98. Based on the distribution chart, Gerresheimer AG ranks #999999 out of 419 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #999999 out of 419 companies for EV-to-FCF. This places Gerresheimer AG in the lower half of its industry. The industry median EV-to-FCF is 22.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.57, based on 419 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current EV-to-FCF is -59.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $109.15, compared to a current price of $30.73 — trading 71.8% below its estimated fair value. The current EV-to-FCF is -59.98. Gerresheimer AG's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current EV-to-FCF is -59.98 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $30.73 is trading 71.8% below its estimated GF Value™ of $109.15.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
EV-to-FCF: -59.98
GF Value™: $109.15 vs. price of $30.73 (71.8% below fair value)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for GRRMF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
